Controversies surrounding lymphadenectomy and postoperative radiotherapy in the treatment of carcinoma of the endometrium

Future Oncology

Volumn 4, Issue 3, 2008, Pages 379-387

  Kohler, Matthew F ^a   Creasman, William T ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Bilateral salpino oophorectomy; Endometrial cancer; Hysterectomy; Lymphadenectomy; Pelvic radiotherapy; Surgical staging

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER GRADING; CANCER INVASION; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DIAGNOSTIC ACCURACY; EARLY INTERVENTION; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; GYNECOLOGY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; LAPAROSCOPIC SURGERY; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; METASTASIS POTENTIAL; MORBIDITY; OBSTETRICS; OVERALL SURVIVAL; PATIENT SAFETY; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION INJURY; RECURRENCE RISK; REIMBURSEMENT; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; ROBOTICS; SALPINGOOOPHORECTOMY; SURGICAL RISK; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT INDICATION;

CLINICAL TRIALS AS TOPIC; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; POSTOPERATIVE PERIOD;

EID: 47249133739     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.4.3.379     Document Type: Review

References (37)

1. Jemal A, Siegal R, Ward E et al.: Cancer Statistics, 2008. CA Cancer J. Clin. 58(2), 71-96 (2008).
2. FIGO: Annual Report on the Results of Treatment in Gynecologic Cancer. Volume 20. FIGO, Milan, Italy, 76 (1988).
3. Lefevre H: Node dissection in cancer of the endometrium. Surg. Gynecol. Obstet. 102, 649 (1956).
4. Morrow CP, DiSaia PJ, Townsend DE: Current management of endometrial carcinoma. Obstet. Gynecol. 42, 399-406 (1973).
5. Creasman WT, Boronow RC, Morrow CP, DiSai PJ, Blessing J: Adenocarcinoma of the endometrium: its metastatic lymph node potential: a preliminary report. Gynecol. Oncol. 4, 239-243 (1976).
6. Boronow RC, Morrow CP, Creasman WT et al.: Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet. Gynecol. 63, 825-832 (1985).
7. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB: Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60, 2035-2041 (1987).
8. Morrow CP, Bundy BN, Kurman RJ et al.: Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group Study. Gynecol. Oncol. 40(1), 55-65 (1991).
9. DiSaia PJ, Creasman WT, Boronow RC, Blessing JA: Risk factors in recurrent patterns in stage I endometrial carcinoma. Am. J. Obstet. Gynecol. 151, 1009-1015 (1985).
10. Announcements: FIGO stages - 1988 Revision. Gynecol. Oncol. 35, 125-127 (1989).
11. Cragun JM, Havrilesky LJ, Calingaert B et al.: Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J. Clin. Oncol. 23, 3668-3675 (2005).
12. Orr JW, Holiman JW, Orr PF: Stage I corpus cancer: Is teletherapy necessary? Am. J. Obstet. Gynecol. 176, 777-789 (1997).
13. Abu-Rustum NR, Alektiar K, Iasonos A et al.: The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol. Oncol. 103, 714-718 (2006).
14. Kendall BS, Ronnett BM, Isacson C et al.: Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am. J. Surg. Pathol. 22(8), 1012-1019 (1998).
15. Sanjuan A, Cobo T, Pahisa J et al.: Preoperative and intraoperative assessment of myometrial invasion and histologic grade in endometrial cancer: role of magnetic resonance imaging and frozen section. Int. J. Gynecol. Cancer 16, 385-390 (2006).
16. Chan JK, Kapp DS: Role of complete lymphadenectomy in endometrioid uterine cancer. Lancet Oncol. 8, 831-841 (2007).
17. Case AS, Rocconi RP, Straughn JM Jr et al.: A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer. Obstet. Gynecol. 108, 1375-1379 (2006).
18. McConkie W, Kachur KH (Eds): CPT Expert 2005. Ingenix Publications, Eden Prairie, MN, USA, p 200 (2005).
19. Mariani A, Dowdy SC, Cliby WA et al.: Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol. Oncol. 109(1), 11-18 (2008).
20. Chan JK, Urban R, Cheung MK et al.: Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients. Cancer 109(12), 2454-2460 (2007).
21. Kilgore LC, Partridge EE, Alvarez RD et al.: Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol. Oncol. 56, 29-33 (1995).
22. Chan JK, Wu H, Cheung MK, Shin JY, Osann K, Kapp DS: The outcomes of 27,063 women with unstaged endometrioid uterine cancer. Gynecol. Oncol. 106, 282-288 (2007).
23. Chuang L, Burke TW, Tornos C et al.: Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. Gynecol. Oncol. 58, 189-193 (1995).
24. Bristow RE, Zahurak ML, Alexander CJ, Zellars RC, Montz FJ: FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Int. J. Gynecol. Cancer 13, 664-672 (2003).
25. Brewster WP, Kurosaki TT, Anton-Culver H et al.: Participation of gynecologic oncologists in the primary surgical management of endometrial cancer in Orange County, California 1985-1994, a population-based study. Gynecol. Oncol. 64(2), 290 (1997).
26. Roland PY, Kelly FJ, Kulwicki CY, Blitzer P, Curcio M, Orr JW Jr: The benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatment. Gynecol. Oncol. 93(1), 125-130 (2004).
27. Macdonald OK, Sause WT, Lee RG, Dodson MK, Zempolich K, Gaffney DK: Does oncologic specialization influence outcomes following surgery in early stage adenocarcinoma of the endometrium? Gynecol. Oncol. 99(3), 730-735 (2005).
28. Walker J, Mannel R, Piedmonte M, Schlaerth J, Spirtos N, Spiegel G: Phase III trial of laparoscopy versus laparotomy for surgical resection and comprehensive surgical staging of uterine cancer: a Gynecologic Oncology Group study funded by the National Cancer Institute. Gynecol. Oncol. 101(Suppl. 1), S11-S12 (2006).
29. Nezhat C, Saberi NS, Shahmohamady B, Nezhat F: Robotic-assisted laparoscopy in gynecological surgery. JSLS 10(3), 317-320 (2006).
30. Kitchener H, Redman CW, Swart AM, Amos CL; on behalf of ASTEC Study Group: ASTEC, A study in the treatment of endometrial cancer. A randomized trial of lymphadenectomy in the treatment of endometrial cancer. Gynecol. Oncol. 101(Suppl. 1), S21-S22 (2006).
31. Barnes MN, Roland PY, Straughn M, Kilgore LC, Alvarez RD, Partridge EE: A comparison of treatment strategies for endometrial adenocarcinoma: analysis of financial impact. Gynecol. Oncol. 74, 443-447 (1999).
32. Cohn DE, Huh WK, Fowler JM, Straughn JM Jr: Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma. Obstet. Gynecol. 109(6), 1388-1395 (2007).
33. Barakat RR, Lev G, Hummer AJ et al.: Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches. Gynecol. Oncol. 105, 150-156 (2007).
34. Aalders J, Abeler V, Kolstad P, Onsrud M: Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma. Clinical and histopathologic study of 540 patients. Obstet. Gynecol. 56, 419-426 (1980).
35. Creutzberg CL, van Putten WLJ, Koper PCM et al.; for the PORTEC Study Group: Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. Lancet 355, 1404-1411 (2000).
36. Keys HM, Roberts JA, Brunetto VL et al.: A Phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol. Oncol. 92, 744-751 (2004).
37. Kong A, Simera I, Collingwood M, Williams C, Kitchener H; on behalf of Cochrane Gynaecological Cancer Group: Adjuvant radiotherapy for stage I endometrial cancer: systematic review and meta-analysis. Ann. Oncol. 18(10), 1595-1604 (2007).